Literature DB >> 15362252

Suicidal ideation in inpatients with acute schizophrenia.

Vassilis Kontaxakis1, Beata Havaki-Kontaxaki, Maria Margariti, Sophia Stamouli, Costas Kollias, George Christodoulou.   

Abstract

OBJECTIVE: Schizophrenia has been associated with a high rate of suicide. This study investigates the prevalence of suicidal ideation in a population of inpatients with acute schizophrenia, together with the clinical parameters associated with suicidal thoughts.
METHOD: We assessed 93 schizophrenia patients. We matched subjects for age and sex and compared subjects with and without suicidal thoughts. We performed stepwise multiple regression analysis to assess the association between specific clinical symptoms and suicidal ideation.
RESULTS: Of the patients, 20.4% reported suicidal thoughts during the last 15 days. Severity of depressive symptoms, motor retardation, guilt feelings, pathological guilt, and self-depreciation predicted the patients' suicidal ideation.
CONCLUSIONS: Suicidal thoughts are frequent among inpatients with acute schizophrenia. Prevention of suicidal behaviour should include helping patients improve their self-esteem and reducing depression and guilt feelings.

Entities:  

Mesh:

Year:  2004        PMID: 15362252     DOI: 10.1177/070674370404900709

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  15 in total

1.  Escape from Discrepancy: Self-Esteem and Quality of Life as Predictors of Current Suicidal Ideation Among Individuals with Schizophrenia.

Authors:  Anthony Fulginiti; John S Brekke
Journal:  Community Ment Health J       Date:  2015-02-15

2.  Assessing suicidal ideation in individuals at clinical high risk for psychosis.

Authors:  Kelly E Gill; Jean M Quintero; S Lucy Poe; Alvaro D Moreira; Gary Brucato; Cheryl M Corcoran; Ragy R Girgis
Journal:  Schizophr Res       Date:  2015-05-07       Impact factor: 4.939

3.  Self-esteem and Symptoms in Individuals at Clinical High Risk for Psychosis.

Authors:  Caridad Benavides; Gary Brucato; David Kimhy
Journal:  J Nerv Ment Dis       Date:  2018-06       Impact factor: 2.254

4.  The subjective consequences of suffering a first episode psychosis: trauma and suicide behaviour.

Authors:  Nicholas Tarrier; Sobia Khan; Joanne Cater; Alicia Picken
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-11-02       Impact factor: 4.328

5.  Co-morbid PTSD and suicidality in individuals with schizophrenia and substance and alcohol abuse.

Authors:  Nicholas Tarrier; Alicia Picken
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-08-15       Impact factor: 4.328

6.  Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition.

Authors:  Emmanuel Stip; Jean Caron; Michel Tousignant; Yves Lecomte
Journal:  Can J Psychiatry       Date:  2017-07-04       Impact factor: 4.356

7.  Sexual obsessions and suicidal behaviors in patients with mood disorders, panic disorder and schizophrenia.

Authors:  Liliana Dell'osso; Giulia Casu; Marina Carlini; Ciro Conversano; Paola Gremigni; Claudia Carmassi
Journal:  Ann Gen Psychiatry       Date:  2012-10-30       Impact factor: 3.455

8.  Suicidal ideation in schizophrenia: A cross-sectional study in a tertiary mental hospital in North-East India.

Authors:  Santanu Nath; Kamal Narayan Kalita; Aparajeeta Baruah; Anantprakash Siddharthkumar Saraf; Diptadhi Mukherjee; Pankaj Kumar Singh
Journal:  Indian J Psychiatry       Date:  2021-04-14       Impact factor: 1.759

9.  The relationship between suicide and violence in schizophrenia: analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset.

Authors:  Katrina Witt; Keith Hawton; Seena Fazel
Journal:  Schizophr Res       Date:  2014-02-26       Impact factor: 4.939

10.  Seasonal Pattern in Suicide in Iran.

Authors:  Mohammad Moqaddasi Amiri; Abdolkarim Ahmadi Livani; Mahmood Moosazadeh; Mohammadreza Mirzajani; Azizallah Dehghan
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.